Detreman

Detreman, containing Rasagiline Tartrate, is an oral medication used to manage symptoms of Parkinson's disease. It belongs to a class of drugs known as monoamine oxidase-B (MAO-B) inhibitors, which help regulate brain chemicals.

Detreman is primarily used to treat the symptoms of Parkinson's disease, a progressive disorder that affects movement. It works by increasing the levels of certain chemicals in the brain, which can help improve motor function and reduce tremors. People often ask, 'What is Detreman used for?' and the answer is that it is designed to alleviate the symptoms associated with Parkinson's disease.

Common effects of Detreman may include improvements in motor function, reduced tremors, and better control of movement. Some individuals may experience side effects such as dizziness, nausea, or headaches. It is important to consult with a healthcare provider to understand the potential effects and benefits.

Detreman should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to exceed it. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Always follow the advice of a healthcare professional when using Detreman.

Detreman may interact with certain foods, beverages, and other medications. It is advisable to avoid consuming foods high in tyramine, such as aged cheeses and cured meats, as they can cause dangerous interactions. Additionally, Detreman should not be taken with other MAO inhibitors or certain antidepressants without medical supervision.